Johannes Gutenberg-Universität Mainz
- 6131/39-0
Zimmer, Sebastian; Goody, Philip Roger; Oelze, Matthias et al.
Inhibition of Rac1 GTPase Decreases Vascular Oxidative Stress, Improves Endothelial Function, and Attenuates Atherosclerosis Development in MiceFRONTIERS IN CARDIOVASCULAR MEDICINE. Bd. 8. 2021
Wachholz, Vanessa; Mustafa, Al-Hassan M.; Zeyn, Yanira et al.
Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3ARCHIVES OF TOXICOLOGY. Bd. 96. H. 1. 2021 S. 177-193
Kretschmer, Alexander; Mazzone, Elio; Barletta, Francesco et al.
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the ProstateEUROPEAN UROLOGY FOCUS. Bd. 7. H. 6. 2021 S. 1247-1253
Wegner, J.; Waisman, A.; von Stebut, E.
Injection of immunocytes into mice with psoriatic skin grafts induces lesion flare up, but no systemic diseaseEXPERIMENTAL DERMATOLOGY. Bd. 30. H. 3. 2021 S. E49-E49
Mohr, A; Bodenstein, M; Sagoschen, I et al.
Inkompatibilitätenreduzierende Infusionschemata für die Arzneimitteltherapie bei IntensivpatientenAnästhesiologie & Intensivmedizin. Bd. 62. 2021 S. 522-537
Jung, Rebecca; Wild, Johannes; Ringen, Julia et al.
Innate Immune Mechanisms of Arterial Hypertension and Autoimmune DiseaseAMERICAN JOURNAL OF HYPERTENSION. Bd. 34. H. 2. 2021 S. 143-153
Almstedt, Katrin; Sehouli, Jalid; Hasenburg, Annette
Innovations in follow-up care and therapy monitoring in ovarian cancer Changes in oncological therapy concepts have an impact on the follow-up care phaseONKOLOGE. Bd. 27. H. 12. 2021 S. 1245-1254
Greinacher, Andreas; Selleng, Kathleen; Palankar, Raghavendra et al.
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopeniaBLOOD. Bd. 138. H. 22. 2021 S. 2256-2268
Chongtham, Monika Chanu; Butto, Tamer; Mungikar, Kanak et al.
INTACT vs. FANS for Cell-Type-Specific Nuclei Sorting: A Comprehensive Qualitative and Quantitative ComparisonINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 22. H. 10. 2021
Pavlakis, N.; Shitara, K.; Sjoquist, K. et al.
INTEGRATE IIb: A randomised phase III open label study of regorafenib plus nivolumab vs standard chemotherapy in refractory advanced gastro-oesophageal cancer (AGOC)ANNALS OF ONCOLOGY. Bd. 32. 2021 S. S1074-S1074